Kolmar Korea Co Ltd is a Korea-based company which is mainly engaged in manufacture and sale of cosmetics. It offers various products such as skin care, makeup, hair care, body care and others. The firm is also involved in development and production of pharmaceutical products and quasi-drugs including general medicines, specialized medicines, bioequivalence medicines and others.
2012
n/a
LTM Revenue $1.7B
LTM EBITDA $205M
$1.8B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Kolmar Korea has a last 12-month revenue of $1.7B and a last 12-month EBITDA of $205M.
In the most recent fiscal year, Kolmar Korea achieved revenue of $1.7B and an EBITDA of $190M.
Kolmar Korea expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Kolmar Korea valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $1.5B | $1.7B | XXX | XXX | XXX |
Gross Profit | $319M | $394M | XXX | XXX | XXX |
Gross Margin | 22% | 24% | XXX | XXX | XXX |
EBITDA | $118M | $190M | XXX | XXX | XXX |
EBITDA Margin | 8% | 11% | XXX | XXX | XXX |
Net Profit | -$15.0M | $3.5M | XXX | XXX | XXX |
Net Margin | -1% | 0% | XXX | XXX | XXX |
Net Debt | $540M | $590M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Kolmar Korea's stock price is KRW 73000 (or $50).
Kolmar Korea has current market cap of KRW 1.72T (or $1.2B), and EV of KRW 2.66T (or $1.8B).
See Kolmar Korea trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$1.8B | $1.2B | XXX | XXX | XXX | XXX | $3.01 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Kolmar Korea has market cap of $1.2B and EV of $1.8B.
Kolmar Korea's trades at 1.1x LTM EV/Revenue multiple, and 8.9x LTM EBITDA.
Analysts estimate Kolmar Korea's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Kolmar Korea and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $1.8B | XXX | XXX | XXX |
EV/Revenue | 1.1x | XXX | XXX | XXX |
EV/EBITDA | 9.6x | XXX | XXX | XXX |
P/E | 19.1x | XXX | XXX | XXX |
P/E/Growth | 0.5x | XXX | XXX | XXX |
EV/FCF | -59.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpKolmar Korea's NTM/LTM revenue growth is 11%
Kolmar Korea's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.
Over next 12 months, Kolmar Korea's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Kolmar Korea's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Kolmar Korea and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 14% | XXX | XXX | XXX | XXX |
EBITDA Margin | 11% | XXX | XXX | XXX | XXX |
EBITDA Growth | 61% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | 23% | XXX | XXX | XXX | XXX |
Revenue per Employee | n/a | XXX | XXX | XXX | XXX |
Opex per Employee | n/a | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | 8% | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 1% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | 1% | XXX | XXX | XXX | XXX |
Opex to Revenue | 21% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Acme United | XXX | XXX | XXX | XXX | XXX | XXX |
EZZ Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
Lavipharm | XXX | XXX | XXX | XXX | XXX | XXX |
Sarantis Group | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Kolmar Korea acquired XXX companies to date.
Last acquisition by Kolmar Korea was XXXXXXXX, XXXXX XXXXX XXXXXX . Kolmar Korea acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was Kolmar Korea founded? | Kolmar Korea was founded in 2012. |
Where is Kolmar Korea headquartered? | Kolmar Korea is headquartered in South Korea. |
Who is the CEO of Kolmar Korea? | Kolmar Korea's CEO is Mr. Hyun-kyu Choi. |
Is Kolmar Korea publicy listed? | Yes, Kolmar Korea is a public company listed on KRX. |
What is the stock symbol of Kolmar Korea? | Kolmar Korea trades under 161890 ticker. |
When did Kolmar Korea go public? | Kolmar Korea went public in 2012. |
Who are competitors of Kolmar Korea? | Similar companies to Kolmar Korea include e.g. Acme United, EZZ Life Science, Live Verdure, Lavipharm. |
What is the current market cap of Kolmar Korea? | Kolmar Korea's current market cap is $1.2B |
What is the current revenue of Kolmar Korea? | Kolmar Korea's last 12-month revenue is $1.7B. |
What is the current EBITDA of Kolmar Korea? | Kolmar Korea's last 12-month EBITDA is $205M. |
What is the current EV/Revenue multiple of Kolmar Korea? | Current revenue multiple of Kolmar Korea is 1.1x. |
What is the current EV/EBITDA multiple of Kolmar Korea? | Current EBITDA multiple of Kolmar Korea is 8.9x. |
What is the current revenue growth of Kolmar Korea? | Kolmar Korea revenue growth between 2023 and 2024 was 14%. |
Is Kolmar Korea profitable? | Yes, Kolmar Korea is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.